228 related articles for article (PubMed ID: 23821228)
1. Monocyte chemoattractant protein-1-deficiency results in altered blood-brain barrier breakdown after experimental stroke.
Strecker JK; Minnerup J; Schütte-Nütgen K; Gess B; Schäbitz WR; Schilling M
Stroke; 2013 Sep; 44(9):2536-44. PubMed ID: 23821228
[TBL] [Abstract][Full Text] [Related]
2. Absence of MCP-induced Protein 1 Enhances Blood-Brain Barrier Breakdown after Experimental Stroke in Mice.
Jin Z; Liang J; Li J; Kolattukudy PE
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261992
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-126-3p/-5p Overexpression Attenuates Blood-Brain Barrier Disruption in a Mouse Model of Middle Cerebral Artery Occlusion.
Pan J; Qu M; Li Y; Wang L; Zhang L; Wang Y; Tang Y; Tian HL; Zhang Z; Yang GY
Stroke; 2020 Feb; 51(2):619-627. PubMed ID: 31822249
[TBL] [Abstract][Full Text] [Related]
4. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.
Ludewig P; Sedlacik J; Gelderblom M; Bernreuther C; Korkusuz Y; Wagener C; Gerloff C; Fiehler J; Magnus T; Horst AK
Circ Res; 2013 Sep; 113(8):1013-22. PubMed ID: 23780386
[TBL] [Abstract][Full Text] [Related]
5. Claudin-1-Dependent Destabilization of the Blood-Brain Barrier in Chronic Stroke.
Sladojevic N; Stamatovic SM; Johnson AM; Choi J; Hu A; Dithmer S; Blasig IE; Keep RF; Andjelkovic AV
J Neurosci; 2019 Jan; 39(4):743-757. PubMed ID: 30504279
[TBL] [Abstract][Full Text] [Related]
6. CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation.
Kim Y; Lee S; Zhang H; Lee S; Kim H; Kim Y; Won MH; Kim YM; Kwon YG
J Neuroinflammation; 2020 Feb; 17(1):48. PubMed ID: 32019570
[TBL] [Abstract][Full Text] [Related]
7. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.
Stamatovic SM; Shakui P; Keep RF; Moore BB; Kunkel SL; Van Rooijen N; Andjelkovic AV
J Cereb Blood Flow Metab; 2005 May; 25(5):593-606. PubMed ID: 15689955
[TBL] [Abstract][Full Text] [Related]
8. Chinese medicine Tongxinluo capsule protects against blood-brain barrier disruption after ischemic stroke by inhibiting the low-density lipoprotein receptor-related protein 1 pathway in mice.
Chang L; Hu L; Wei C; Zhang H; Liu S
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105071. PubMed ID: 32807473
[TBL] [Abstract][Full Text] [Related]
9. The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.
Shan Y; Tan S; Lin Y; Liao S; Zhang B; Chen X; Wang J; Deng Z; Zeng Q; Zhang L; Wang Y; Hu X; Qiu W; Peng L; Lu Z
J Neuroinflammation; 2019 Nov; 16(1):242. PubMed ID: 31779652
[TBL] [Abstract][Full Text] [Related]
10. Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model.
Hughes PM; Allegrini PR; Rudin M; Perry VH; Mir AK; Wiessner C
J Cereb Blood Flow Metab; 2002 Mar; 22(3):308-17. PubMed ID: 11891436
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemoattractant protein-1-deficiency impairs the expression of IL-6, IL-1β and G-CSF after transient focal ischemia in mice.
Strecker JK; Minnerup J; Gess B; Ringelstein EB; Schäbitz WR; Schilling M
PLoS One; 2011; 6(10):e25863. PubMed ID: 22031820
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of interleukin-9 ameliorates experimental stroke by repairing the blood-brain barrier via down-regulation of astrocyte-derived vascular endothelial growth factor-A.
Tan S; Shan Y; Lin Y; Liao S; Zhang B; Zeng Q; Wang Y; Deng Z; Chen C; Hu X; Peng L; Qiu W; Lu Z
FASEB J; 2019 Mar; 33(3):4376-4387. PubMed ID: 30694693
[TBL] [Abstract][Full Text] [Related]
13. Orosomucoid1: Involved in vascular endothelial growth factor-induced blood-brain barrier leakage after ischemic stroke in mouse.
Wu L; Jiang Y; Zhu J; Wen Z; Xu X; Xu X; Xie Y; Yang L; Xu L; Lan W; Xu G; Liu X
Brain Res Bull; 2014 Oct; 109():88-98. PubMed ID: 25264156
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of brain ATP-binding cassette transporter A-1 exacerbates blood-brain barrier and white matter damage after stroke.
Cui X; Chopp M; Zacharek A; Karasinska JM; Cui Y; Ning R; Zhang Y; Wang Y; Chen J
Stroke; 2015 Mar; 46(3):827-34. PubMed ID: 25593138
[TBL] [Abstract][Full Text] [Related]
15. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice.
Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
Stroke; 2007 Apr; 38(4):1345-53. PubMed ID: 17332467
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells.
Chen Y; Hallenbeck JM; Ruetzler C; Bol D; Thomas K; Berman NE; Vogel SN
J Cereb Blood Flow Metab; 2003 Jun; 23(6):748-55. PubMed ID: 12796723
[TBL] [Abstract][Full Text] [Related]
17. Cerebralcare Granule® attenuates blood-brain barrier disruption after middle cerebral artery occlusion in rats.
Huang P; Zhou CM; Qin-Hu ; Liu YY; Hu BH; Chang X; Zhao XR; Xu XS; Li Q; Wei XH; Mao XW; Wang CS; Fan JY; Han JY
Exp Neurol; 2012 Oct; 237(2):453-63. PubMed ID: 22868201
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia.
Wang Y; Jia J; Ao G; Hu L; Liu H; Xiao Y; Du H; Alkayed NJ; Liu CF; Cheng J
J Neurochem; 2014 Jun; 129(5):827-38. PubMed ID: 24673410
[TBL] [Abstract][Full Text] [Related]
19. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
[TBL] [Abstract][Full Text] [Related]
20. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke.
Kahles T; Luedike P; Endres M; Galla HJ; Steinmetz H; Busse R; Neumann-Haefelin T; Brandes RP
Stroke; 2007 Nov; 38(11):3000-6. PubMed ID: 17916764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
